c-Met activation in HCC is mostly driven by molecular networks instead of activating mutations and it is activated by non-canonical signaling mechanisms as well as canonical activation by its ligand, hepatocyte growth factor (HGF). This evidence concerns the gene MET and hepatocellular carcinoma.